2Nakamura T,Ushiyama C,Suzuki S,et al.Urinary excretion of podocytes in patients with diabetic nephrophthy[J].Nephrol Dial Transplant,2000,15(9):1379-1383.
4GRUNDY S M, BENJAMIN I J, BURKE G L, et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association[J]. Circulation, 1999, 100(10): 1134-1146.
5DEATH A K, FISHER E J, MCGRATH K C, et al. High glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetes [J]. Atherosclerosis, 2003, 168(2): 263-269.
6MORISHIGE K, SHIMOKAWA H, MATSUMOTO Y, et al. Overexpression of matrix metalloproteinase-9 promotes intravascular thrombus formation in porcine eoronary arteries in vivo[J]. Cardiovase Res, 2003, 57(2): 572-585.
7PASTERKAMP G, SCHONEVELD A H, HIJNEN D J, et al. Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery[J]. Atherosclerosis, 2000, 150(2): 245-253.
8WOESSNER J F JR. That impish TIMP: the tissue inhibitor of metalloproteinases-3 [J]. J Clin Invest, 2001, 108 (6) : 799 -800.
9BEAUDEUX J L, GIRAL P, BRUCKERT E, et al. Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives[J]. Clin Chem Lab Med, 2004, 42 (2) : 121-131.
10MOREAU M, BROCHERIOU I, PETIT L, et al. Interleukin-8 mediates downregulation of tissue inhibitor of metalloproteinase-1 expression in cholesterol-loaded human macrophages: relevance to stability of atherosclerotic plaque [J]. Circulation, 1999, 99(3): 420-426.
